Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II

US9771359B1 · kind B1 · utility

Assignee

• MEDIFRON DBT INC. · KR

Inventors

• Robert Frank-Foltyn · Bad Mergentheim, DE
• Christopher Habermann · Aachen, DE
• Gregor Bahrenberg · Monschau, DE
• Bernhard Lesch · Aachen, DE
• Nils Damann · Bad Mergentheim, DE
• Klaus Schiene · Goldkronach, DE
• Hannelore Stockhausen · Nideggen, DE
• Thomas Christoph · Aachen, DE
• Sven Frormann · Aachen, DE
• Derek Saunders · Aachen, DE
• Jeewoo Lee · Ansan-si, KR

Key dates

• Filing date: May 23, 2017
• Grant date: Sep 26, 2017
• Expiry date: May 23, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.